fflissue plasminogen activator initiates fibrinolysis I bV activation o[ plasminogen to plasmin in as-I sociation with fibrin.r'2 The activity of TPA is regulated by its major physiological inhibitor, PAI-1. 3 Much evidence indicates that elevated levels of PAI-1 are associated with the incidence of atherothrombotic episodes.a Moreover, elevated levels of PAI-1 are associated with obesity,5 non-insulin-dependent diabetes," and/or insulin resistanceT and, more generally, with the features of syndrome X.E Epidemiological studies suggest that elevated plasma triglycerides constitute a risk factor for vascular disease.e In the Framingham Study, men and women with triglyceride levels >1.7 mmol/L and HDL levels <1.03 mmol/L had a high rate of coronary heart disease,lo and the PROCAM study showed hypertriglyceridemia to be a powerfil risk factor when combined with a high ratio (>5.0) of plasma LDL to HDL cholesterol.ll In hypertriglyceridemic patients, the plasma fìbrino-lytic capacity is reduced because of elevated levels of PAI-1 in plasma,r2-1s and a direct correlation between triglyceride leveis and PAI-1 activity or antigen has been reported.ìs '16 The synthesis of PAI-1 by endothelial, smooth muscle, or liver cells is regulated by several substances. '7 To triglyceride transport, increases PAI-1 biosynthesis in endothelial cells. This effect is more pronounced when cells are incubated with VLDL isolated from plasma of hypertriglyceridemic patients, which suggests a direct effect of the lipoprotein on PAI-1 antigen biosynthesis.rs, 18 The greater effect of VLDL from hypertriglyceridemic patients than that from normolipidemic subjects may be due to the presence in the former of larger VLDL particles containing newly transferred apoE that have high affinity for the apoB/E receptor present on endothelial cells.l8 ' We have previously demonstratedls'1e that VLDL from both normal subjects gene, and no detectable signal was given by the pBR322 used as a negative control (Fig 7) .
To determine whether modulation of PAI-1 mRNA levels by VLDL was due to an induced change in stability of PAI-1 mRNA, actinomycin D (10 g.g/ml-) was added to cells previously kept for 16 
